Login / Signup

Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin.

Tommaso BucciDennis WatDilip NazarethSarah SibleyDaniel G WoottonGregory Yoke Hong LipFrederick Frost
Published in: American journal of respiratory and critical care medicine (2024)
Keyphrases
  • cardiovascular events
  • low dose
  • coronary artery disease
  • chronic obstructive pulmonary disease
  • cardiovascular disease
  • cystic fibrosis
  • high dose
  • type diabetes